Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Learnings from a Double-Blind, Randomized, Placebo-Controlled, Sequential Group First-in-Human Study of the TRPV1 antagonist, JNJ-38893777, in Healthy Me